Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

1st Optimal vs LumiMeds

1st Optimal
Graded #288

Lower grade

vs+6.999999999999993
LumiMeds
Graded #143

Higher grade

The verdict

LumiMeds takes it — 68.6/100 to 61.6/100.

LumiMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth provider with flat-rate compounded GLP-1 pricing on a 3-month plan.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLumiMeds +32
45
77
Dose & formulationLumiMeds +13
51
64
Clinical oversightLumiMeds +5
77
82
Labs & monitoring1st Optimal +44
97
53
FulfillmentLumiMeds +5
60
65
Contract termsLumiMeds +18
37
55
1st Optimal · left barLumiMeds · right bar

The numbers

Metric1st OptimalLumiMeds
WeighScore61.6/10068.6/100
GradeCC
Scorecard rank#288#143
SemaglutideNot disclosed$133/mo (starting dose, compounded)
TirzepatideNot disclosed$133/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
1st Optimal

Graded #288 · C

Strengths

  • Offers both semaglutide and tirzepatide with injectable and oral formats
  • Functional-medicine approach with at-home labs and blood-work interpretation
  • Unlimited coaching and ongoing support included
  • No long-term contracts
  • Board-certified doctors and nurse practitioners referenced

Where it loses points

  • No public monthly pricing disclosed
  • No published state availability list
  • Compounded vs branded sourcing not clarified on site
  • Pricing only revealed after quiz or consultation
LumiMeds

Graded #143 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard